Therapeutic Payload Delivery to the Myocardium: Evolving Strategies and Obstacles

Overview

Journal JTCVS Open

Specialty Cardiology & Vascular Diseases

Date 2022 Aug 25

PMID 36004211

Authors

Tarek Shazly

Arianna Smith

Mark J Uline

Francis G Spinale

Affiliations

Soon will be listed here.

Citing Articles

Intrapericardial Administration to Achieve Localized and Targeted Treatment for Cardiac Disease.

Xu Y, Chen Y, Tan J, Ooi J, Guo Z J Cardiovasc Transl Res. 2024; 18(1):28-39.

PMID: 39164600 DOI: 10.1007/s12265-024-10553-3.

Percutaneous Alginate Hydrogel Endomyocardial Injection with a Novel Dedicated Catheter Delivery System: An Animal Feasibility Study.

Wang B, Gao C, Lim S, Wang R, Zhu C, Onuma Y J Cardiovasc Transl Res. 2024; 17(4):842-850.

PMID: 38376702 PMC: 11371841. DOI: 10.1007/s12265-024-10497-8.

Current Landscape of Gene Therapy for the Treatment of Cardiovascular Disorders.

Wal P, Aziz N, Singh C, Rasheed A, Tyagi L, Agrawal A Curr Gene Ther. 2024; 24(5):356-376.

PMID: 38288826 DOI: 10.2174/0115665232268840231222035423.

References

Fisher S, Zhang H, Doree C, Mathur A, Martin-Rendon E . Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev. 2015; (9):CD006536. PMC: 8572033. DOI: 10.1002/14651858.CD006536.pub4. View

van Brakel T, Hermans J, Accord R, Schotten U, Smits J, Allessie M . Effects of intrapericardial sotalol and flecainide on transmural atrial electrophysiology and atrial fibrillation. J Cardiovasc Electrophysiol. 2009; 20(2):207-15. DOI: 10.1111/j.1540-8167.2008.01318.x. View

Perin E, Willerson J, Pepine C, Henry T, Ellis S, Zhao D . Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA. 2012; 307(16):1717-26. PMC: 3600947. DOI: 10.1001/jama.2012.418. View

Ayers G, Rho T, Ben-David J, Besch Jr H, Zipes D . Amiodarone instilled into the canine pericardial sac migrates transmurally to produce electrophysiologic effects and suppress atrial fibrillation. J Cardiovasc Electrophysiol. 1996; 7(8):713-21. DOI: 10.1111/j.1540-8167.1996.tb00579.x. View

Jadczyk T, Ciosek J, Michalewska-Wludarczyk A, Szot W, Parma Z, Ochala B . Effects of trans-endocardial delivery of bone marrow-derived CD133+ cells on angina and quality of life in patients with refractory angina: A sub-analysis of the REGENT-VSEL trial. Cardiol J. 2018; 25(4):521-529. DOI: 10.5603/CJ.2018.0082. View

Filgueira C, Igo S, Wang D, Hirsch M, Schulz D, Bruckner B . Technologies for intrapericardial delivery of therapeutics and cells. Adv Drug Deliv Rev. 2019; 151-152:222-232. DOI: 10.1016/j.addr.2019.02.006. View

de la Fuente L, Stertzer S, Argentieri J, Penaloza E, Miano J, Koziner B . Transendocardial autologous bone marrow in chronic myocardial infarction using a helical needle catheter: 1-year follow-up in an open-label, nonrandomized, single-center pilot study (the TABMMI study). Am Heart J. 2007; 154(1):79.e1-7. DOI: 10.1016/j.ahj.2007.04.051. View

Shuman J, Zurcher J, Sapp A, Burdick J, Gorman R, Gorman 3rd J . Localized targeting of biomaterials following myocardial infarction: a foundation to build on. Trends Cardiovasc Med. 2013; 23(8):301-11. PMC: 3773006. DOI: 10.1016/j.tcm.2013.04.004. View

Toma C, Pittenger M, Cahill K, Byrne B, Kessler P . Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002; 105(1):93-8. DOI: 10.1161/hc0102.101442. View

10.

Hamamoto H, Gorman 3rd J, Ryan L, Hinmon R, Martens T, Schuster M . Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage. Ann Thorac Surg. 2009; 87(3):794-801. PMC: 3021253. DOI: 10.1016/j.athoracsur.2008.11.057. View

11.

Haley K, Almas T, Shoar S, Shaikh S, Azhar M, Cheema F . The role of anti-inflammatory drugs and nanoparticle-based drug delivery models in the management of ischemia-induced heart failure. Biomed Pharmacother. 2021; 142:112014. DOI: 10.1016/j.biopha.2021.112014. View

12.

Quevedo H, Hatzistergos K, Oskouei B, Feigenbaum G, Rodriguez J, Valdes D . Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci U S A. 2009; 106(33):14022-7. PMC: 2729013. DOI: 10.1073/pnas.0903201106. View

13.

Garcia J, Campbell P, Kumar G, Langberg J, Cesar L, Deppen J . Minimally Invasive Delivery of Hydrogel-Encapsulated Amiodarone to the Epicardium Reduces Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2018; 11(5):e006408. PMC: 5951400. DOI: 10.1161/CIRCEP.118.006408. View

14.

Tucker-Schwartz J, Gillies G, Scanavacca M, Sosa E, Mahapatra S . Pressure-frequency sensing subxiphoid access system for use in percutaneous cardiac electrophysiology: prototype design and pilot study results. IEEE Trans Biomed Eng. 2009; 56(4):1160-8. DOI: 10.1109/TBME.2008.2009527. View

15.

Vicario J, Campos C, Piva J, Faccio F, Gerardo L, Becker C . Transcoronary sinus administration of autologous bone marrow in patients with chronic refractory stable angina Phase 1. Cardiovasc Radiat Med. 2004; 5(2):71-6. DOI: 10.1016/j.carrad.2004.06.004. View

16.

Gathier W, van Ginkel D, van der Naald M, van Slochteren F, Doevendans P, Chamuleau S . Retrograde Coronary Venous Infusion as a Delivery Strategy in Regenerative Cardiac Therapy: an Overview of Preclinical and Clinical Data. J Cardiovasc Transl Res. 2018; 11(3):173-181. PMC: 5973989. DOI: 10.1007/s12265-018-9785-1. View

17.

Seferovic P, Ristic A, Maksimovic R, Petrovic P, Ostojic M, Simeunovic S . Initial clinical experience with PerDUCER device: promising new tool in the diagnosis and treatment of pericardial disease. Clin Cardiol. 1999; 22(1 Suppl 1):I30-5. PMC: 6655979. DOI: 10.1002/clc.4960221309. View

18.

Bolderman R, Hermans J, Rademakers L, de Jong M, Bruin P, Dias A . Epicardial application of an amiodarone-releasing hydrogel to suppress atrial tachyarrhythmias. Int J Cardiol. 2010; 149(3):341-6. DOI: 10.1016/j.ijcard.2010.02.014. View

19.

McMahan S, Taylor A, Copeland K, Pan Z, Liao J, Hong Y . Current advances in biodegradable synthetic polymer based cardiac patches. J Biomed Mater Res A. 2020; 108(4):972-983. PMC: 7030941. DOI: 10.1002/jbm.a.36874. View

20.

Kang S, Yang Y, Li C, Gao R . Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials. Coron Artery Dis. 2008; 19(5):327-35. DOI: 10.1097/MCA.0b013e328300dbd3. View